An emerging generation of endocrine therapies in breast cancer: a clinical perspective

Metastatic HR+/HER2 - Breast Cancer - Market Insights

Emerging Endocrine Therapies for the Management of Breast Cancer

CDK4/6i-treated HR+/HER2- breast cancer tumors show higher ESR1

Cancers, Free Full-Text

Updates in endocrine therapy for metastatic breast cancer

Hazard ratios for estrogen receptor–positive invasive breast

Pharmaceutics, Free Full-Text

Pharmaceutics, Free Full-Text

Whole-Genome Sequencing Analysis of Male Breast Cancer Unveils Novel Structural Events and Potential Therapeutic Targets - Modern Pathology

Circulating tumor DNA validity and potential uses in metastatic

Updates in endocrine therapy for metastatic breast cancer

Results from clinical trials of next-generation endocrine

Pharmaceutics, Free Full-Text

ESR1 mutation as an emerging clinical biomarker in metastatic